Tian An Medicare expects H1 profit attributable to shareholders of HK$30 million-HK$60 million

• Tian An Medicare flagged a rise in profit attributable to shareholders to HK$30 million-HK$60 million for the six months ended June 30, 2026.
• That compares with HK$12 million a year earlier.
• Guidance reflects higher Healthcare Division revenue, lower non-cash fair-value losses on investment properties, higher fair-value gains on trading investments.
• Offset in part by a smaller net foreign-exchange gain versus the prior-year period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tian An Medicare Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260807-12277195), on August 07, 2026, and is solely responsible for the information contained therein.